PL1883665T3 - Kompozycje polilaktydowe i ich zastosowania - Google Patents

Kompozycje polilaktydowe i ich zastosowania

Info

Publication number
PL1883665T3
PL1883665T3 PL06809004T PL06809004T PL1883665T3 PL 1883665 T3 PL1883665 T3 PL 1883665T3 PL 06809004 T PL06809004 T PL 06809004T PL 06809004 T PL06809004 T PL 06809004T PL 1883665 T3 PL1883665 T3 PL 1883665T3
Authority
PL
Poland
Prior art keywords
polylactide compositions
polylactide
compositions
Prior art date
Application number
PL06809004T
Other languages
English (en)
Inventor
Michael Moller
Thomas Trimaille
Robert Gurny
Original Assignee
Universite De Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite De Geneve filed Critical Universite De Geneve
Publication of PL1883665T3 publication Critical patent/PL1883665T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
PL06809004T 2005-04-22 2006-04-21 Kompozycje polilaktydowe i ich zastosowania PL1883665T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67410305P 2005-04-22 2005-04-22
US75014105P 2005-12-14 2005-12-14
EP06809004.2A EP1883665B1 (en) 2005-04-22 2006-04-21 Polylactide compositions and uses thereof
PCT/IB2006/002849 WO2007012979A2 (en) 2005-04-22 2006-04-21 Polylactide compositions and uses thereof

Publications (1)

Publication Number Publication Date
PL1883665T3 true PL1883665T3 (pl) 2018-05-30

Family

ID=37603048

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06809004T PL1883665T3 (pl) 2005-04-22 2006-04-21 Kompozycje polilaktydowe i ich zastosowania

Country Status (9)

Country Link
US (5) US8466133B2 (pl)
EP (2) EP3339348B1 (pl)
JP (5) JP5749881B2 (pl)
CA (1) CA2605652C (pl)
DK (1) DK1883665T3 (pl)
ES (1) ES2646141T3 (pl)
PL (1) PL1883665T3 (pl)
PT (1) PT1883665T (pl)
WO (1) WO2007012979A2 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5749881B2 (ja) * 2005-04-22 2015-07-15 ユニヴェルシテ デ ジュネーブ ポリラクチド組成物およびその使用
WO2008121702A2 (en) * 2007-03-28 2008-10-09 Boston Scientific Scimed, Inc. Medical devices having bioerodable layers for the release of therapeutic agents
US20100159011A1 (en) * 2007-08-03 2010-06-24 University Of Massachusetts Medical School Compositions For Biomedical Applications
US8697098B2 (en) * 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
CN101665566B (zh) * 2008-09-01 2012-01-04 南京工业大学 一种利用双螺杆挤出机制备聚乳酸及其制品的方法
FR2942800B1 (fr) * 2009-03-06 2012-04-20 Minasolve Procede de polymerisation par voie catalytique de 1,4-dioxanes-2,5 diones et les polymeres correspondants
CA2824250A1 (en) * 2010-01-08 2011-07-14 University Of Prince Edward Island Star polymers having controlled tacticity and methods of making same
DK2598553T3 (da) * 2010-07-26 2016-08-01 Univ Geneve Sammensætninger omfattende polymerer fremstillede af 2-hydroxyalkylsyrer
EP2678001B1 (en) 2011-02-25 2017-04-05 South Dakota State University Polymer conjugated protein micelles
WO2013083605A1 (en) 2011-12-05 2013-06-13 Ferring Bv Triptorelin pharmaceutical composition
WO2013113820A1 (en) 2012-02-02 2013-08-08 Esbatech - A Novartis Company Llc Antibody-containing sustained-release formulation for ocular administration
AR090736A1 (es) * 2012-04-20 2014-12-03 Sucampo Ag Conjugado de compuesto triciclo-polimero
AR092821A1 (es) * 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
EA027829B1 (ru) * 2013-02-08 2017-09-29 Тотал Ресерч & Технолоджи Фелай Способ получения циклических эфиров и циклических амидов
US9080012B2 (en) * 2013-07-10 2015-07-14 Xerox Corporation One-pot, neat ring opening polymerization to prepare resin
US8975344B2 (en) * 2013-07-10 2015-03-10 Xerox Corporation Polyester/polycarbonate block copolymers via one-pot, neat ring opening polymerization
DE102013018193A1 (de) 2013-10-30 2015-05-13 Martin-Luther-Universität Halle-Wittenberg, Körperschaft des öffentlichen Rechts Injizierbare Depotformulierungen zur kontrollierten Wirkstofffreisetzung
EP3110451B1 (en) * 2014-02-26 2020-08-19 University of Massachusetts Medical School Amphiphilic degradable polymers for immobilization and sustained delivery of biomolecules
DE102014005782A1 (de) 2014-04-23 2015-10-29 Martin-Luther-Universität Halle-Wittenberg lnjizierbare und implantierbare Trägersysteme auf Basis von modifizierten Poly(dikarbonsäure-multiol estern) zur kontrollierten Wirkstofffreisetzung
JP6557722B2 (ja) 2014-05-30 2019-08-07 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための生分解性脂質
US20180327589A1 (en) * 2014-11-17 2018-11-15 Roquette Freres Composition comprising a mixture of polyesters and thermoplastic starch, having improved film-forming ability
WO2016100520A1 (en) * 2014-12-16 2016-06-23 Boston Scientific Scimed, Inc. Bioerodible polymer compositions
US9260550B1 (en) 2015-01-27 2016-02-16 International Business Machines Corporation Lactide-based acrylate polymers
JP6148701B2 (ja) * 2015-07-31 2017-06-14 ユニベルシテ ドゥ ジュネーブ ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
US10202489B2 (en) 2017-03-08 2019-02-12 International Business Machines Corporation Lactide copolymers and ring-opened lactide copolymers
US10072121B1 (en) 2017-03-08 2018-09-11 International Business Machines Corporation Bottlebrush polymers derived from poly(methylidenelactide)
US10035877B1 (en) 2017-03-08 2018-07-31 International Business Machines Corporation Matrix-bondable lactide monomors for polylactide synthesis
US10570252B2 (en) 2017-03-08 2020-02-25 International Business Machines Corporation Flame retardant lactide monomors for polylactide synthesis
US20210038563A1 (en) 2018-01-26 2021-02-11 Apidel Sa New spironolactone formulations and their use
CA2994005A1 (fr) * 2018-02-05 2019-08-05 Hydro-Quebec Copolymeres d'unites ester et ether, leurs procedes de fabrication et leurs utilisations
EP3656378A1 (en) * 2018-11-26 2020-05-27 ValMeyer Sàrl New composition of amide and ester local anesthetics and uses thereof
US11407855B2 (en) 2019-08-23 2022-08-09 The Board Of Trustees Of The University Of Illinois Ring opening polymerization in an aqueous dispersion

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
CA2110899C (en) 1991-06-21 2006-08-08 Jacob G. Michael Orally administrable therapeutic proteins and method of making
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
CA2087125A1 (en) * 1992-01-23 1993-07-24 Mridula Nair Chemically fixed micelles
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5686630A (en) * 1993-09-29 1997-11-11 Chronopol, Inc. Purifying cyclic esters by aqueous solvent extraction
DE69312487T2 (de) 1992-05-18 1997-11-27 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
KR970002523B1 (en) * 1993-04-24 1997-03-05 Korea Inst Sci & Tech Biodegradable polylactic acid having improved properties and method for manufacturing the same
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6007845A (en) * 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5580579A (en) 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
US6469133B2 (en) * 1999-12-13 2002-10-22 Board Of Trustees Of Michigan State University Process for the preparation of polymers of dimeric cyclic esters
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
KR100484371B1 (ko) 2001-10-25 2005-04-20 가부시키가이샤 아텍스 히터선부착 시트체의 제조방법
AU2003258230A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc Medical device exhibiting improved adhesion between polymeric coating and substrate
AU2003275263A1 (en) * 2002-09-26 2004-04-19 Angiotech International Ag Perivascular wraps
US7533176B2 (en) 2004-07-14 2009-05-12 International Business Machines Corporation Method for supporting connection establishment in an offload of network protocol processing
JP5749881B2 (ja) * 2005-04-22 2015-07-15 ユニヴェルシテ デ ジュネーブ ポリラクチド組成物およびその使用

Also Published As

Publication number Publication date
US8466133B2 (en) 2013-06-18
JP2014065722A (ja) 2014-04-17
WO2007012979A2 (en) 2007-02-01
EP1883665A2 (en) 2008-02-06
CA2605652C (en) 2016-05-24
DK1883665T3 (da) 2017-11-13
JP2016128506A (ja) 2016-07-14
US9925267B2 (en) 2018-03-27
EP3339348B1 (en) 2019-12-04
JP2008538589A (ja) 2008-10-30
US20180271984A1 (en) 2018-09-27
JP2015038121A (ja) 2015-02-26
PT1883665T (pt) 2017-11-14
JP6491614B2 (ja) 2019-03-27
US20090281068A1 (en) 2009-11-12
JP6346540B2 (ja) 2018-06-20
US20160367680A1 (en) 2016-12-22
JP2017222712A (ja) 2017-12-21
EP1883665B1 (en) 2017-10-11
CA2605652A1 (en) 2007-02-01
US9375482B2 (en) 2016-06-28
WO2007012979A3 (en) 2007-05-03
ES2646141T3 (es) 2017-12-12
US20150073060A1 (en) 2015-03-12
US20130331464A1 (en) 2013-12-12
US10314913B2 (en) 2019-06-11
JP6559198B2 (ja) 2019-08-14
EP3339348A1 (en) 2018-06-27
US8741877B2 (en) 2014-06-03
JP5749881B2 (ja) 2015-07-15

Similar Documents

Publication Publication Date Title
PT1883665T (pt) Composições polilactídeo e usos das mesmas
EP1895838A4 (en) COMPOSITIONS AND METHODS
GB0515052D0 (en) Organosiloxane compositions
GB0522287D0 (en) Method and compositions
EP2015781A4 (en) COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF
GB0506939D0 (en) Organosiloxane compositions
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
EP1968526A4 (en) FOAMING DENTAL COMPOSITIONS AND METHODS
ZA200704295B (en) Arthrospira-based compositions and uses thereof
PL1976548T3 (pl) Fragmenty VIP i ich kompozycje
EP1874348A4 (en) IMMUNOMODULATING COMPOSITIONS AND THEIR USES
IL184834A0 (en) Compositions and methods for the manufacture thereof
EP1848438A4 (en) DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE
GB0622399D0 (en) Novel compositions and uses thereof
EP1991059A4 (en) INSECTICIDAL COMPOSITIONS AND USES THEREOF
GB0524927D0 (en) Compositions and method
ZA200805079B (en) Immunostimulatory compositions and methods
IL186337A0 (en) Stannsoporfin compositions and administration
EP1998753A4 (en) COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF
GB0513431D0 (en) Prophylactic compositions and uses
EP1937292A4 (en) LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
GB2423081B (en) Pro-fragrance and pro-flavorant compositions
ZA200707529B (en) Pro-fragrance and pro-flavorant compositions
GB0622400D0 (en) Novel compositions and uses thereof
GB0501348D0 (en) Compositions and methods